Buspirone Treatment of Cannabis Dependence: A Randomized, Placebo-Controlled Trial

BACKGROUND: The purpose of this study was to evaluate the efficacy of buspirone, a partial 5-HT1A agonist, for treatment of cannabis dependence. METHODS: One hundred seventy-five cannabis-dependent adults were randomized to receive either up to 60 mg/day of buspirone (n=88) or placebo (n=87) for twe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Alcohol Depend
Autors principals: McRae-Clark, Aimee L., Baker, Nathaniel L., Gray, Kevin M., Killeen, Therese K., Wagner, Amanda M., Brady, Kathleen T., DeVane, C. Lindsay, Norton, Jessica
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633378/
https://ncbi.nlm.nih.gov/pubmed/26386827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.08.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars